The boom of copyright’s drug initially fueled significant progress in the medicinal sector, creating a perception of guaranteed gains. However, placing capital in companies solely reliant on flagship drugs like https://emilydqqz577703.blog5star.com/41487954/the-blue-pill-and-big-pharma-a-risky-play